Curis Inc (CRIS) director receives 6,800 stock options at $5.29
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CURIS INC director Martyn D. Greenacre received a grant of options on 6,800 shares of common stock. These non-qualified stock options have an exercise price of $5.29 per share and expire on July 6, 2036. The options vest 100% on July 7, 2027, aligning compensation with longer-term performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
GREENACRE MARTYN D
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non Qualified Stock Option | 6,800 | $5.29 | $36K |
Holdings After Transaction:
Non Qualified Stock Option — 6,800 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 6,800 options
Exercise price: $5.29 per share
Expiration date: July 6, 2036
+2 more
5 metrics
Options granted
6,800 options
Non-qualified stock option grant to director on July 7, 2026
Exercise price
$5.29 per share
Strike price for the 6,800 non-qualified stock options
Expiration date
July 6, 2036
Final expiration of the reported option grant
Vesting date
July 7, 2027
Options vest 100% on this date per footnote
Options held after grant
6,800 options
Total derivative securities held following the reported transaction
Key Terms
Non Qualified Stock Option, exercise price, expiration date, underlying shares
4 terms
Non Qualified Stock Option financial
"security_title: Non Qualified Stock Option"
exercise price financial
"transaction_price_per_share: 5.2900 as the exercise price per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-07-06T00:00:00.000Z for the option grant"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did CURIS INC (CRIS) director Martyn D. Greenacre report on this Form 4?
Director Martyn D. Greenacre reported receiving a grant of non-qualified stock options for 6,800 shares of Curis common stock. These options are part of his equity compensation and represent an acquisition, not an open-market purchase or sale of shares.
What are the key terms of Martyn D. Greenacre’s 6,800 CURIS INC stock options?
The reported non-qualified stock options cover 6,800 shares at an exercise price of $5.29 per share. They expire on July 6, 2036, providing a long exercise window tied to Curis’s future share price performance over the coming years.
When do Martyn D. Greenacre’s CURIS INC options vest according to the Form 4?
The Form 4 footnote states that the option grant vests as to 100% of the underlying 6,800 shares on July 7, 2027. Until that vesting date, the options generally cannot be exercised under the terms described.
How many CURIS INC options does Martyn D. Greenacre hold after this grant?
After this transaction, the filing shows Greenacre directly holding 6,800 non-qualified stock options. These options are exercisable into an equal number of Curis common shares once vested, subject to their July 7, 2027 vesting and July 6, 2036 expiration terms.
What does the $5.29 exercise price mean for the CURIS INC option grant?
The $5.29 exercise price is the cost per share Greenacre must pay to convert each option into Curis common stock. The options gain value only if Curis’s market price exceeds $5.29 after the July 7, 2027 vesting date and before expiration.